Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Wenger

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
BIO26-035: Validation of an Electronic Health Record Phenotype for Advanced Solid Cancer Across Five University of California Health SystemsAnne M Walling, Rachael Sak, Samuel Skootsky, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
BIO26-035: MTAP Deficiency in Thoracic Oncology: Bridging Genomic Loss, Survival Deficits, and Immunosuppressive MicroenvironmentsAnne M Walling, Rachael Sak, Samuel Skootsky, et al.
Trials|March 26, 2026
Optimizing Primary Care Tools for Incontinence MAnagement (OPTIMA): protocol for a cluster randomized controlled trialMaxwell B Moore, Kyle Okamuro, Catherine Bresee, et al.
Breast Cancer Research and Treatment|September 16, 2021
The WISDOM study: a new approach to screening can and should be testedLaura Esserman, Martin Eklund, Laura Van't Veer, et al.
Arthritis Care & Research|October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaDinesh Khanna, John D Fitzgerald, Puja P Khanna, et al.
Arthritis Care & Research|October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritisDinesh Khanna, Puja P Khanna, John D Fitzgerald, et al.
Human Genetics|February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
JAMA Internal Medicine|December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical TrialKirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al.
Research Square|November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and DesignAllison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
NPJ Breast Cancer|May 23, 2026
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and designAllison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
BIO26-035: Validation of an Electronic Health Record Phenotype for Advanced Solid Cancer Across Five University of California Health SystemsAnne M Walling, Rachael Sak, Samuel Skootsky, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
BIO26-035: MTAP Deficiency in Thoracic Oncology: Bridging Genomic Loss, Survival Deficits, and Immunosuppressive MicroenvironmentsAnne M Walling, Rachael Sak, Samuel Skootsky, et al.
Trials|March 26, 2026
Optimizing Primary Care Tools for Incontinence MAnagement (OPTIMA): protocol for a cluster randomized controlled trialMaxwell B Moore, Kyle Okamuro, Catherine Bresee, et al.
Breast Cancer Research and Treatment|September 16, 2021
The WISDOM study: a new approach to screening can and should be testedLaura Esserman, Martin Eklund, Laura Van't Veer, et al.
Arthritis Care & Research|October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaDinesh Khanna, John D Fitzgerald, Puja P Khanna, et al.
Arthritis Care & Research|October 2, 2012
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritisDinesh Khanna, Puja P Khanna, John D Fitzgerald, et al.
Human Genetics|February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
JAMA Internal Medicine|December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical TrialKirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al.
Research Square|November 19, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and DesignAllison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
NPJ Breast Cancer|May 23, 2026
WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and designAllison Fiscalini, Kelly Blum, Kirkpatrick Fergus, et al.
Pageof 6